{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:19:07Z","timestamp":1777922347023,"version":"3.51.4"},"reference-count":22,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Monoclonal Antibodies in Immunodiagnosis &amp; Immunotherapy"],"published-print":{"date-parts":[[2016,6]]},"abstract":"<jats:p>Pancreatic ductal adenocarcinoma is an aggressive tumor with a poor prognosis. Biomarkers that can detect the tumor in its early stages when it may be amenable to curative resection might improve prognosis. To discover novel markers expressed in primary pancreatic cancer, we generated a panel of monoclonal antibodies against pancreatic ductal adenocarcinoma cell line BxPC3 using a rat medial iliac lymph node method. The antigen recognized by 1B5A5 was expressed on the cell surface and secreted into the conditioned medium of BxPC3 cells, and characterized as glycoproteins with molecular mass between 60 and 90\u2009kDa. A wide range of molecular weights of 1B5A5 antigen in several pancreatic cancer cell lines were observed. Immunohistochemistry using a human multiple organ tumor tissue array showed an enhanced expression of 1B5A5 antigen in pancreas, lung, stomach, breast, urinary bladder, colon, and cervix uteri cancers. Immunoprecipitation followed by proteomic analyses identified CEACAM6 as a 1B5A5 antigen. In addition, western blot analysis results indicated that the 1B5A5 epitope is located within an amino-terminal domain of CEACAM6. These results raised the possibility that our approach could lead to discovery of novel biomarkers for the early stage of cancers in a relatively short period of time.<\/jats:p>","DOI":"10.1089\/mab.2016.0012","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T12:49:10Z","timestamp":1463057350000},"page":"148-154","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Generation of Rat Monoclonal Antibodies Against Human Pancreatic Ductal Adenocarcinoma Cells"],"prefix":"10.1177","volume":"35","author":[{"given":"Kiyoshi","family":"Higashi","sequence":"first","affiliation":[{"name":"Sumitomo Chemical Co., Ltd.","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Fujii","sequence":"additional","affiliation":[{"name":"Osaka City University","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Kushida","sequence":"additional","affiliation":[{"name":"Sumitomo Chemical Co., Ltd.","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Yamada","sequence":"additional","affiliation":[{"name":"Osaka Ohtani University","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Sumitomo Chemical Co., Ltd.","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Saito","sequence":"additional","affiliation":[{"name":"Sumitomo Chemical Co., Ltd.","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Tachibana","sequence":"additional","affiliation":[{"name":"Osaka City University","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2016,6]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20006"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2014.10.001"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2008.12.031"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01542654"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.2174\/157489211795328549"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.550848"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2014.0075"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006767405609"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1089\/hyb.2009.0101"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.151936"},{"key":"e_1_3_2_12_2","first-page":"596","article-title":"Establishment of a carcinoembryonic antigen-producing cell line from pancreatic carcinoma","volume":"71","author":"Kaku M","year":"1980","unstructured":"Kaku M, , Nishiyama T, , Yagawa K, , and Abe M: Establishment of a carcinoembryonic antigen-producing cell line from pancreatic carcinoma. Gan, 1980; 71:596\u2013601.","journal-title":"Gan"},{"key":"e_1_3_2_13_2","first-page":"54","article-title":"Establishment and characterization of a human pancreatic cancer cell line (SUIT-2) producing carcinoembryonic antigen and carbohydrate antigen 19-9","volume":"78","author":"Iwamura T","year":"1987","unstructured":"Iwamura T, , Katsuki T, , and Ide K: Establishment and characterization of a human pancreatic cancer cell line (SUIT-2) producing carcinoembryonic antigen and carbohydrate antigen 19-9. Jpn J Cancer Res, 1987; 78:54\u201362.","journal-title":"Jpn J Cancer Res"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13193-011-0042-1"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.1860050510"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-013-9444-6"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000067255"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.115.6.1273"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.108.069872"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-014-1688-1"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-7-2"},{"key":"e_1_3_2_22_2","volume-title":"AACR Annual Meeting","author":"Strickland LA","unstructured":"Strickland LA, , Risser P, , Verbeke C, , Polakis P, , and Koeppen H: Evaluation of efficacy and toxicity of CEACAM6 targeted immunotherapy in pancreatic ductal adenocarcinoma. AACR Annual Meeting, Anaheim, California 2005: Abstract no. 4195."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2707"}],"container-title":["Monoclonal Antibodies in Immunodiagnosis &amp; Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/mab.2016.0012","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mab.2016.0012","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mab.2016.0012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:18:09Z","timestamp":1777666689000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/mab.2016.0012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["10.1089\/mab.2016.0012"],"URL":"https:\/\/doi.org\/10.1089\/mab.2016.0012","relation":{},"ISSN":["2167-9436","2167-9436"],"issn-type":[{"value":"2167-9436","type":"print"},{"value":"2167-9436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}